Fitch Assigns "A-" Rating to Thermo Fisher's Planned Senior Notes | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Following Thermo Fisher Scientific's announcement today that it will issue senior notes to fund in part its $3.5 billion acquisition of Phadia, ratings agency Fitch assigned an "A-" rating to the notes.

Thermo Fisher has not yet disclosed the terms of the notes or how much it expects to raise in the offering.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.